Efficacy and safety of convalescent plasma versus standard care in hospitalized patients with COVID-19 from the Peruvian Social Security Health System: open-label …
C Villanueva, I Neyra, A Sagastegui, A Chunga… - medRxiv, 2022 - medrxiv.org
ABSTRACT OBJECTIVES To assess the efficacy and safety of convalescent plasma plus
standard of care (CP+ SoC) compared with standard of care (SoC) alone in patients …
standard of care (CP+ SoC) compared with standard of care (SoC) alone in patients …
Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
potential treatment of COVID-19. However, meta-analysis data and recommendations are …
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from randomized clinical trials, matched control, case series, and case …
patient outcome data from randomized clinical trials, matched control, case series, and case …
Terapia con plasma de convaleciente para pacientes con COVID-19: Revisión de la literatura
S Llocclla Delgado, T Platero Portillo… - Revista de la …, 2020 - inicib.urp.edu.pe
La enfermedad del coronavirus 2019 (COVID-19) causada por la infección por el nuevo
coronavirus (SARS-CoV-2) ha creado una pandemia que ha llevado a una lucha mundial …
coronavirus (SARS-CoV-2) ha creado una pandemia que ha llevado a una lucha mundial …
Terapia de plasma convaleciente para pacientes con Covid-19: Revisión de la literatura
T Platero-Portillo, S Llocclla-Delgado… - Revista de la Facultad …, 2020 - scielo.org.pe
Introducción: La enfermedad por coronavirus 2019 (COVID-19) causada por la infección por
el nuevo coronavirus (SARS-CoV-2) ha creado una pandemia que ha llevado a una lucha …
el nuevo coronavirus (SARS-CoV-2) ha creado una pandemia que ha llevado a una lucha …
Plasma Convaleciente, rol en el tratamiento de COVID-19
M Díaz - sidalc.net
Disertación realizada el 28 de julio 2020. El Dr. Miguel Díaz del Hospital Rawson de la
provincia de Córdoba, integrante del equipo que investiga la utilización del plasma …
provincia de Córdoba, integrante del equipo que investiga la utilización del plasma …
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured …
A Soto, F Krapp, A Vargas, L Cabrejos, E Argumanis… - Trials, 2021 - Springer
Objectives The general objective of this study is to test the hypothesis that administration of
convalescent plasma from donors with previous diagnosis of severe COVID-19 pneumonia …
convalescent plasma from donors with previous diagnosis of severe COVID-19 pneumonia …
[PDF][PDF] LETTER Open Access
A Soto, F Krapp, A Vargas, L Cabrejos… - 2021 - trialsjournal.biomedcentral.com
Objectives: The general objective of this study is to test the hypothesis that administration of
convalescent plasma from donors with previous diagnosis of severe COVID-19 pneumonia …
convalescent plasma from donors with previous diagnosis of severe COVID-19 pneumonia …
A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia
L Thorlacius-Ussing, PT Brooks, H Nielsen… - Scientific Reports, 2022 - nature.com
Passive immunotherapy with convalescent plasma may be the only available agent during
the early phases of a pandemic. Here, we report safety and efficacy of high-titer …
the early phases of a pandemic. Here, we report safety and efficacy of high-titer …
[HTML][HTML] Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial
Background Randomized trials are generally performed from a frequentist perspective,
which can conflate absence of evidence with evidence of absence. The RECOVERY trial …
which can conflate absence of evidence with evidence of absence. The RECOVERY trial …